What is the appropriate treatment and workup for erythema nodosum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Erythema Nodosum: Treatment and Workup

Diagnose erythema nodosum clinically based on tender, raised, red-to-violet subcutaneous nodules (1-5cm) on the anterior lower legs, and treat the underlying cause while providing symptomatic relief with NSAIDs and rest. 1

Clinical Diagnosis

Erythema nodosum is readily recognized without biopsy in typical presentations 1. Look for:

  • Bilateral, symmetrical tender nodules on pretibial areas (shins)
  • Size: 1-5 cm diameter
  • Color evolution: bright red → livid/purplish → yellow/greenish (bruise-like)
  • Associated systemic symptoms: arthralgia, fatigue
  • Never ulcerates and resolves without scarring 2, 3

Reserve skin biopsy only for atypical presentations 1. If performed, histology shows septal panniculitis without vasculitis, with Miescher's radial granulomas 3.

Diagnostic Workup Algorithm

The workup prioritizes identifying treatable underlying causes, as approximately 50% of cases are idiopathic 4.

Initial Laboratory Studies (All Patients):

  • Complete blood count with differential
  • ESR and/or CRP
  • Throat culture or rapid strep test
  • Anti-streptolysin O (ASO) titer
  • Chest radiograph 4, 2

Risk-Stratified Additional Testing:

High-risk tuberculosis patients (endemic regions, immunosuppressed):

  • Tuberculin skin test or QuantiFERON
  • Sputum AFB culture if indicated 5

Guided by clinical suspicion:

  • Stool cultures (if GI symptoms suggest inflammatory bowel disease)
  • Medication review (oral contraceptives, antibiotics, bisphosphonates) 2, 6
  • Pregnancy test (women of childbearing age)
  • Further imaging or serologies only if history/exam suggests specific systemic disease

Treatment Strategy

Primary Principle: Treat the Underlying Cause

For IBD-associated erythema nodosum: Treatment of the underlying bowel disease typically resolves lesions within weeks 7. In inflammatory bowel disease flares, erythema nodosum parallels disease activity 1.

Symptomatic Management (All Cases):

First-line:

  • Bed rest and leg elevation 4, 3
  • NSAIDs (full doses): indomethacin, naproxen, or aspirin 8, 3

Severe cases:

  • Systemic corticosteroids 1

Relapsing or resistant forms:

  • Immunomodulators: azathioprine
  • Anti-TNF agents: infliximab or adalimumab 1

Key Clinical Pitfalls

  1. Do not confuse with metastatic Crohn's disease, which can appear as nodules but shows non-caseating granulomas on biopsy and can occur anywhere on the body 1

  2. Rule out infection before starting corticosteroids - particularly tuberculosis in endemic regions or high-risk patients 3, 5

  3. Most cases are self-limited (3-6 weeks), so avoid overtreatment 8, 3

  4. Higher prevalence in women and Crohn's disease > ulcerative colitis among IBD patients 1

  5. Consider medication-induced causes - recent case reports link zoledronic acid (bisphosphonates) to erythema nodosum 6

Natural History

Erythema nodosum typically resolves spontaneously within 3-6 weeks with complete skin recovery 8. Relapses are uncommon except in idiopathic cases or streptococcal-associated disease 8. The condition represents a type IV delayed hypersensitivity reaction to various antigenic stimuli 9, 2.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.